ASAleksandra V. Sagaidak

Aleksandra V. Sagaidak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandra V. Sagaidak has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nanoparticle Behavior in the Body: Biochemical, Pharmacological and Cellular Aspects

    by Rodion G. Sakhabeev, Arina V. Ilina, Inga A. Gorbacheva, Elizaveta N. Sezganova, Anna S. Rogova, Aleksandra V. Sagaidak, Dmitry O. Vinokhodov, Maxim Shevtsov

    The behavior of nanoparticles (NPs) in the body is a complex, multilevel process governed by a cascade of physicochemical and biological interactions. At the molecular level, these processes include protein adsorption and formation of the biomolecular corona, ion release, and surface redox reactions. At the cellular level, they encompass endocytosis, intracellular trafficking, lysosomal processing and clearance, and redistribution within cellular compartments. At the systemic level, NPs undergo tissue and organ biodistribution, biological barrier crossing, biotransformation, biodegradation, elimination, and immunomodulation. Understanding these processes is essential for evaluating the safety, efficacy, and therapeutic potential of nanomedicines, as the unique physicochemical properties of NPs can induce biological responses that differ substantially from those of their bulk counterparts. This review provides an integrated framework for understanding the absorption, distribution, biotransformation, and elimination of NPs in biological systems. Particular emphasis is placed on the molecular and cellular mechanisms governing nanoparticle–biological interactions, including the effects of NPs on cellular energy metabolism through interactions with the mitochondrial electron transport chain and their immunomodulatory effects mediated by nuclear factor κB (NF-κB) signaling and inflammasome activation. By integrating molecular, cellular, and systemic perspectives, this review highlights the key determinants of nanoparticle fate in the body and their implications for the design, safety, and clinical translation of nanomedicines.

  • HCT116 cell line heterogeneity: A useful tool for preclinical research

    by Tatyana A. Grigoreva, Aleksandra V. Sagaidak, Daria N. Kindt, Anastasiya D. Zenina, Angelina A. Romanova, Gleb S. Ivanov, Tatyana K. Yakovleva, Viktoriya I. Turilova, Vyacheslav G. Tribulovich


  • Open Access

    The Managed Acquisition of Chemoresistance as an Informative Tool for Tumor Research

    by Tatyana A. Grigoreva, Daria N. Kindt, Aleksandra V. Sagaidak, Angelina A. Romanova, Vyacheslav G. Tribulovich

    The problem of acquiring chemoresistance by tumor cells is a growing concern for researchers as the effectiveness of diagnosis and treatment of primary tumors increases. To study the mechanisms of resistance, as well as to evaluate the effectiveness of new drugs, it is necessary to use adequate cell models. The review presents modern methods for obtaining chemoresistant cell lines used by researchers in such studies. It examines the most common cytostatics and targeted drugs, such as cisplatin, oxaliplatin, paclitaxel, doxorubicin, 5-fluorouracil, gemcitabine, gefitinib, bortezomib, erlotinib, and the monoclonal antibody cetuximab. Particular attention is paid to cell mechanisms activated due to drug resistance development and to methods of cell cultivation in the presence of drugs. The presented information provides an opportunity to discuss trends in the creation of chemoresistant cell lines for further research on resistance mechanisms and the development of new therapeutic strategies.


  • Open Access

    Cellular Systems for Colorectal Stem Cancer Cell Research

    by Tatyana A. Grigoreva, Daria N. Kindt, Aleksandra V. Sagaidak, Daria S. Novikova, Vyacheslav G. Tribulovich

    Oncological diseases consistently occupy leading positions among the most life-threatening diseases, including in highly developed countries. At the same time, the second most common cause of cancer death is colorectal cancer. The current level of research shows that the development of effective therapy, in this case, requires a new grade of understanding processes during the emergence and development of a tumor. In particular, the concept of cancer stem cells that ensure the survival of chemoresistant cells capable of giving rise to new tumors is becoming widespread. To provide adequate conditions that reproduce natural processes typical for tumor development, approaches based on increasingly complex cellular systems are being improved. This review discusses the main strategies that allow for the study of the properties of tumor cells with an emphasis on colorectal cancer stem cells. The features of working with tumor cells and the advantages and disadvantages of 2D and 3D culture systems are considered.


  • Open Access

    A Visual Compendium of Principal Modifications within the Nucleic Acid Sugar Phosphate Backbone

    by Daria Novikova, Aleksandra Sagaidak, Svetlana Vorona, Vyacheslav Tribulovich

    Nucleic acid chemistry is a huge research area that has received new impetus due to the recent explosive success of oligonucleotide therapy. In order for an oligonucleotide to become clinically effective, its monomeric parts are subjected to modifications. Although a large number of redesigned natural nucleic acids have been proposed in recent years, the vast majority of them are combinations of simple modifications proposed over the past 50 years. This review is devoted to the main modifications of the sugar phosphate backbone of natural nucleic acids known to date. Here, we propose a systematization of existing knowledge about modifications of nucleic acid monomers and an acceptable classification from the point of view of chemical logic. The visual representation is intended to inspire researchers to create a new type of modification or an original combination of known modifications that will produce unique oligonucleotides with valuable characteristics.


  • Open Access

    New Insights into Chemoresistance Mediated by Mdm2 Inhibitors: The Benefits of Targeted Therapy over Common Cytostatics

    by Tatyana Grigoreva, Aleksandra Sagaidak, Daria Novikova, Vyacheslav Tribulovich

    The inhibition of the Mdm2-p53 protein–protein interaction is a promising strategy for anticancer therapy. However, the problem of developing secondary chemoresistance in tumors treated with such drugs has not yet been sufficiently studied. In this work, we compared the properties of a drug-resistant cell line obtained during long-term cultivation in the presence of an Mdm2 inhibitor, Nutlin-3a, with a similarly obtained line insensitive to the cytostatic drug paclitaxel. We first confirmed the higher safety levels of Mdm2 inhibitors when compared with cytostatics in terms of the development of secondary chemoresistance. We showed that Nutlin-3a affects both the targeted p53-mediated cellular machinery and the universal ABC-mediated efflux mechanism. While both targeted and general defense mechanisms are activated by the Mdm2 inhibitor, it still increases the susceptibility of tumor cells to other drugs. The results obtained indicate that the risks of developing chemoresistance under the therapy with a targeted agent are fundamentally lower than during cytotoxic therapy.


  • ATP Mimetic Attack on the Nucleotide-Binding Domain to Overcome ABC Transporter Mediated Chemoresistance

    by Tatyana A. Grigoreva, Aleksandra V. Sagaidak, Svetlana V. Vorona, Daria S. Novikova, Vyacheslav G. Tribulovich

    Since the problem of transporter-mediated multidrug resistance of tumor cells is becoming increasingly important in cancer therapy, it is necessary to modulate the activity of efflux transporters of the ABC family, among which P-glycoprotein is the best known. We consider the nucleotide binding domain, a universal fragment of these transporters, as a target for the rational design of small molecule compounds capable of preventing ATP-dependent drug efflux. Using various ATP mimetics, we showed that they suppress the efflux of fluorescent substrates and paclitaxel from the cells due to suppressing the ATPase activity of the transporters. The combined use of paclitaxel and ATP mimetics significantly increases its antitumor efficacy, including in cells with the multidrug resistance phenotype. The considered compounds are promising agents for the development of therapeutic efflux modulators, since they are not toxic at the given concentrations and do not induce the transporter overexpression. Moreover, the compounds overcome not only P-gp-mediated but also BCRP-mediated resistance of tumor cells.


  • Implication of ABC transporters in non-proliferative diseases

    by Tatyana A. Grigoreva, Aleksandra V. Sagaidak, Daria S. Novikova, Vyacheslav G. Tribulovich